163 related articles for article (PubMed ID: 28411282)
1. Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report.
Vujkovic M; Attiyeh EF; Ries RE; Goodman EK; Ding Y; Kavcic M; Alonzo TA; Wang YC; Gerbing RB; Sung L; Hirsch B; Raimondi S; Gamis AS; Meshinchi S; Aplenc R
Blood; 2017 Jun; 129(23):3051-3058. PubMed ID: 28411282
[TBL] [Abstract][Full Text] [Related]
2. Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.
Laszlo GS; Alonzo TA; Gudgeon CJ; Harrington KH; Gerbing RB; Wang YC; Ries RE; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Walter RB
Clin Cancer Res; 2015 Jul; 21(14):3187-95. PubMed ID: 25825478
[TBL] [Abstract][Full Text] [Related]
3. Copy-number analysis identified new prognostic marker in acute myeloid leukemia.
Nibourel O; Guihard S; Roumier C; Pottier N; Terre C; Paquet A; Peyrouze P; Geffroy S; Quentin S; Alberdi A; Abdelali RB; Renneville A; Demay C; Celli-Lebras K; Barbry P; Quesnel B; Castaigne S; Dombret H; Soulier J; Preudhomme C; Cheok MH
Leukemia; 2017 Mar; 31(3):555-564. PubMed ID: 27686867
[TBL] [Abstract][Full Text] [Related]
4. Presence of copy number aberration and clinical prognostic factors in patients with acute myeloid leukemia: an analysis of effect modification.
Bănescu C; Tripon F; Trifa AP; Crauciuc AG; Bogliș A; Lazar E; Dima D; Macarie I; Duicu C; Iancu M
Pol Arch Intern Med; 2019 Dec; 129(12):898-906. PubMed ID: 31808755
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia.
Tao Y; Wei L; Shiba N; Tomizawa D; Hayashi Y; Ogawa S; Chen L; You H
Mol Biomed; 2024 Jan; 5(1):1. PubMed ID: 38163849
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report From the Children's Oncology Group.
Getz KD; Sung L; Ky B; Gerbing RB; Leger KJ; Leahy AB; Sack L; Woods WG; Alonzo T; Gamis A; Aplenc R
J Clin Oncol; 2019 Jan; 37(1):12-21. PubMed ID: 30379624
[TBL] [Abstract][Full Text] [Related]
7. The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology Group.
Ho PA; Alonzo TA; Gerbing RB; Kuhn J; Pollard JA; Hirsch B; Raimondi SC; Gamis AS; Meshinchi S
Pediatr Blood Cancer; 2014 Jan; 61(1):81-8. PubMed ID: 23956224
[TBL] [Abstract][Full Text] [Related]
8. Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.
Loken MR; Alonzo TA; Pardo L; Gerbing RB; Raimondi SC; Hirsch BA; Ho PA; Franklin J; Cooper TM; Gamis AS; Meshinchi S
Blood; 2012 Aug; 120(8):1581-8. PubMed ID: 22649108
[TBL] [Abstract][Full Text] [Related]
9. High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.
Walter RB; Alonzo TA; Gerbing RB; Ho PA; Smith FO; Raimondi SC; Hirsch BA; Gamis AS; Franklin JL; Hurwitz CA; Loken MR; Meshinchi S
J Clin Oncol; 2010 Jun; 28(17):2831-8. PubMed ID: 20421533
[TBL] [Abstract][Full Text] [Related]
10. Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: a report from the Children's Oncology Group.
Vujkovic M; Attiyeh EF; Ries RE; Horn M; Goodman EK; Ding Y; Kavcic M; Alonzo TA; Gerbing RB; Hirsch B; Raimondi S; Gamis AS; Meshinchi S; Aplenc R
Cancer Genet; 2015; 208(7-8):408-13. PubMed ID: 26163103
[TBL] [Abstract][Full Text] [Related]
11. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
Pediatr Blood Cancer; 2010 Sep; 55(3):414-20. PubMed ID: 20658610
[TBL] [Abstract][Full Text] [Related]
12. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
13. Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome.
Forero-Castro M; Robledo C; Benito R; Abáigar M; África Martín A; Arefi M; Fuster JL; de Las Heras N; Rodríguez JN; Quintero J; Riesco S; Hermosín L; de la Fuente I; Recio I; Ribera J; Labrador J; Alonso JM; Olivier C; Sierra M; Megido M; Corchete-Sánchez LA; Ciudad Pizarro J; García JL; Ribera JM; Hernández-Rivas JM
PLoS One; 2016; 11(2):e0148972. PubMed ID: 26872047
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center.
Jaime-Pérez JC; Padilla-Medina JR; Fernández LT; Herrera-Garza JL; Gutiérrez-Aguirre CH; Tarín-Arzaga L; Gómez-Almaguer D
Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):286-292. PubMed ID: 29478946
[TBL] [Abstract][Full Text] [Related]
15. miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.
Ramamurthy R; Hughes M; Morris V; Bolouri H; Gerbing RB; Wang YC; Loken MR; Raimondi SC; Hirsch BA; Gamis AS; Oehler VG; Alonzo TA; Meshinchi S
Pediatr Blood Cancer; 2016 Dec; 63(12):2096-2103. PubMed ID: 27511899
[TBL] [Abstract][Full Text] [Related]
16. ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial.
Rafiee R; Chauhan L; Alonzo TA; Wang YC; Elmasry A; Loken MR; Pollard J; Aplenc R; Raimondi S; Hirsch BA; Bernstein ID; Gamis AS; Meshinchi S; Lamba JK
Blood Cancer J; 2019 May; 9(6):51. PubMed ID: 31113932
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of pretreatment telomere length as a prognostic marker in intermediate-risk acute myeloid leukemia.
Gu R; Cao J; Wei S; Gong X; Wang Y; Mi Y; Zhang J; Qiu S; Rao Q; Wang M; Wei H; Wang J
Int J Lab Hematol; 2021 Dec; 43(6):1510-1515. PubMed ID: 34288423
[TBL] [Abstract][Full Text] [Related]
18. Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the NOPHO-AML 2004 study.
Tierens A; Bjørklund E; Siitonen S; Marquart HV; Wulff-Juergensen G; Pelliniemi TT; Forestier E; Hasle H; Jahnukainen K; Lausen B; Jonsson OG; Palle J; Zeller B; Fogelstrand L; Abrahamsson J
Br J Haematol; 2016 Aug; 174(4):600-9. PubMed ID: 27072379
[TBL] [Abstract][Full Text] [Related]
19. Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531.
Voigt AP; Brodersen LE; Alonzo TA; Gerbing RB; Menssen AJ; Wilson ER; Kahwash S; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Wells DA; Loken MR
Haematologica; 2017 Dec; 102(12):2058-2068. PubMed ID: 28883080
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis.
Wu X; Wang H; Deng J; Zheng X; Ling Y; Gong Y
Ann Hematol; 2019 Nov; 98(11):2485-2496. PubMed ID: 31482295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
